BioScience Health Innovations, Inc. financial data

Symbol
BHIC on OTC
Location
2722 S West Temple, Salt Lake City, UT
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 7, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Debt-to-equity 13.3 % -83.9%
Return On Equity 90.8 %
Return On Assets 80.2 %
Operating Margin 22.8 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 43.9M shares +4.32%
Common Stock, Shares, Outstanding 43.9M shares +5.58%
Entity Public Float 41.6M USD
Common Stock, Value, Issued 4.39K USD +5.58%
Weighted Average Number of Shares Outstanding, Basic 43.9M shares +5.58%
Weighted Average Number of Shares Outstanding, Diluted 44.3M shares +5.52%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 4.17M USD +260%
Research and Development Expense 37.5K USD +4563%
Operating Income (Loss) 951K USD +517%
Income Tax Expense (Benefit) 0 USD
Net Income (Loss) Attributable to Parent 951K USD +517%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.3M USD +803%
Accounts Receivable, after Allowance for Credit Loss, Current 390K USD +1312%
Inventory, Net 249K USD +512%
Assets, Current 1.99M USD +829%
Intangible Assets, Net (Excluding Goodwill) 72.1K USD
Assets 2.06M USD +863%
Accounts Payable, Current 16.6K USD +137%
Accrued Liabilities, Current 24.5K USD +1125%
Liabilities 338K USD +1278%
Retained Earnings (Accumulated Deficit) 543K USD
Stockholders' Equity Attributable to Parent 1.72M USD +810%
Liabilities and Equity 2.06M USD +863%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 328K USD
Net Cash Provided by (Used in) Financing Activities 67.5K USD -44.5%
Net Cash Provided by (Used in) Investing Activities -30K USD
Common Stock, Shares Authorized 75M shares 0%
Common Stock, Shares, Issued 43.9M shares +5.58%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.3M USD +803%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD
Deferred Tax Assets, Valuation Allowance 49K USD -33.1%
Deferred Tax Assets, Operating Loss Carryforwards 47.4K USD -5.43%
Preferred Stock, Shares Issued 140K shares 0%
Preferred Stock, Shares Authorized 140K shares 0%
Additional Paid in Capital 1.17M USD +97.9%
Preferred Stock, Shares Outstanding 140K shares 0%
Deferred Tax Assets, Net of Valuation Allowance 0 USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%